Sunvozertinib (DZD9008) is an oral, potent, irreversible, and selective EGFR TKI targeting EGFR exon20ins as well as EGFR sensitizing,…
About Vebreltinib Vebreltinib (also known as bozitinib) is a pharmaceutical drug used for the treatment of…
INDICATIONS AND USAGE Afatinib is a kinase inhibitor indicated for: • First-line treatment of patients with…
INDICATIONS AND USAGE Erlotinib is a kinase inhibitor indicated for: · The treatment of patients with metastatic…
INDICATIONS AND USAGE Dacomitinib is a kinase inhibitor indicated for the first-line treatment of patients with…
TYVYT® (sintilimab injection) is a fully human IgG4 monoclonal antibody, which specifically binds to PD-1 expressed on…
About Savolitinib Savolitinib is an oral, potent, and highly selective MET TKI that has demonstrated clinical…
About Aumolertinib Aumolertinib (previously known as almonertinib) is a EGFR tyrosine kinase inhibitor targeting EGFR-sensitizing and T790M…
About Furmonertinib Furmonertinib Mesilate acts as an anti-cancer agent. It is formulated as tablets for oral…
About Tepotinib Tepotinib is a kinase inhibitor directed against MET, including variants with exon 14 skipping…
About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
ABout Crizotinib Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer…
About Repotrectinib Repotrectinib is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is taken by mouth. Repotrectinib is…
Serplulimab, a recombinant humanised anti-PD-1 monoclonal antibody (mAb) injection, is the first innovative monoclonal antibody developed…
Trametinib is a kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers…
Dabrafenib is an anti-cancer medication used for the treatment of cancers associated with a mutated version of the…
Copyright © 2021-2022 LienTeh.net All rights reserved.
